[MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy].
Mild Cognitive Impairment (MCI) is a prevalent problem in the elderly and many patients show predictors of rapid cognitive decline ("MCI-plus"). MCI-plus represents a syndrome with growing importance in an ageing society, which will increasingly affect primary medicine and most other clinical specialties. We will have to face the dilemma of fast progress in the field of neurodiagnostics with innovative therapeutic strategies lagging behind. Psychological and medical co-morbidity in MCI-plus will therefore offer important opportunities to delay and to avoid the manifestation of dementia. We will review and discuss current training and treatment options including symptomatic and causal interventions.
Förstl
H
H
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, München, Germany. hans.foerstl@lrz.tu-muenchen.de
Bickel
H
H
Frölich
L
L
Gertz
H J
HJ
Gutzmann
H
H
Hörr
R
R
Pantel
J
J
Schmidt
R
R
Schönknecht
P
P
Ulm
K
K
Werheid
K
K
D000375:Aging / Q000502:physiology / Q000523:psychology*; D003072:Cognition Disorders / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D015897:Comorbidity; D018450:Disease Progression; D006801:Humans; D012307:Risk Factors; D013577:Syndrome